[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy (Q80501660)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

main subject

neoadjuvant chemotherapy

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Alina Berriolo-Riedinger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Claude Touzery

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Jean-Marc Riedinger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Michel Toubeau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Laurent Arnould

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Christophe Boichot

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Alexandre Cochet

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Pierre Fumoleau

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

François Brunotte

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

20 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

number of pages

10

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1915-1924

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-007-0459-5

1 January 2020

exact match

0 references

cites work

Performance of a whole-body PET scanner using curve-plate NaI(Tl) detectors.

1 reference

12 December 2020

Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer

1 reference

12 December 2020

A formula to estimate the approximate surface area if height and weight be known. 1916.

1 reference

12 December 2020

Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose

1 reference

12 December 2020

Neoadjuvant 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer

1 reference

12 December 2020

Evolving role of positron emission tomography in breast cancer imaging

1 reference

12 December 2020

Standardized uptake values of FDG: body surface area correction is preferable to body weight correction.

1 reference

12 December 2020

Use of PET to monitor the response of lung cancer to radiation treatment

1 reference

12 December 2020

Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy

1 reference

12 December 2020

Randomized parallel study of doxorubicin plus paclitaxel and doxorubicin plus cyclophosphamide as neoadjuvant treatment of patients with breast cancer

1 reference

12 December 2020

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

1 reference

12 December 2020

Clinical role of FDG PET in evaluation of cancer patients

1 reference

12 December 2020

Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography

1 reference

12 December 2020

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil

1 reference

12 December 2020

Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography

1 reference

12 December 2020

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation

1 reference

12 December 2020

Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy

1 reference

12 December 2020

Influence of the blood glucose concentration on FDG uptake in cancer--a PET study.

1 reference

12 December 2020

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

1 reference

12 December 2020

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

12 December 2020

Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.

1 reference

12 December 2020

Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients

1 reference

12 December 2020

Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome

1 reference

12 December 2020

Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study.

1 reference

12 December 2020

Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding

1 reference

12 December 2020

Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer

1 reference

12 December 2020

Positron emission tomography using [18F]fluorotamoxifen to evaluate therapeutic responses in patients with breast cancer: preliminary study

1 reference

12 December 2020

Accuracy of contrast-enhanced computed tomography in the prediction of residual breast cancer after neoadjuvant chemotherapy

1 reference

12 December 2020

A row-action alternative to the EM algorithm for maximizing likelihood in emission tomography.

1 reference

12 December 2020

Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.

1 reference

12 December 2020

Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation

1 reference

12 December 2020

Pathological assessment of response to induction chemotherapy in breast cancer

1 reference

12 December 2020

Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma

1 reference

12 December 2020

FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.

1 reference

12 December 2020

Evaluation of therapy response in breast and ovarian cancer patients by positron emission tomography (PET).

1 reference

12 December 2020

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

12 December 2020

Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer

1 reference

12 December 2020

10.1007/S00259-007-0459-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17579854%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference